top-selling glp-1 medications in the u.s. 2025 Top Selling Drugs of – M A N O X B L O G Market Overview: GLP-1 Agonists and

A.GaoS.HassanM

Once-Weekly Cagrilintide for Weight Management in Adults With Overweight and Obesity: A Phase 2 Trial

Jul 24 2025;26(15)doi:10.3390/ijms26157159 Wallace TC, Fulgoni VL, 3rd

People with prediabetes, type 2 diabetes, or obesity starting weight management programs gain valuable insights from comprehensive metabolic monitoring

staggered titration Cycle driver GI tolerance sets the pace Retatrutide Loading 2 mg 4 mg 8 mg (weeks 1-12) Frequency Once weekly Maintenance 12 mg weekly Route SubQ Cagrilintide Loading Start Week 9: 0.25 0.5 1.0 1.7 mg Frequency Once weekly Maintenance 2.4 mg weekly Route SubQ Weekly Schedule Example (Maintenance Phase) Monday Retatrutide 12 mg (one site) + Cagrilintide 2.4 mg (different site) Tuesday No injections Wednesday No injections Thursday No injections Friday No injections Saturday No injections Sunday No injections Both compounds are once-weekly

Incidence of type 1 and type 2 diabetes in adults and children in Kronoberg, Sweden